Japneet Kaur

Postdoctoral fellow

UAMS

15 h-index 103 pubs 623 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

Japneet Kaur's research focuses on cellular senescence and its role in age-related disorders, particularly within the skeletal system. Her work investigates the mechanisms of senescence in osteocytes and the potential of senolytic therapies to mitigate age-associated bone conditions. Kaur has contributed to studies examining the effects of both local and systemic senolysis in aged mice, assessing the impact on skeletal health and the broader benefits of clearing senescent cells.

Her research also extends to the in vitro and in vivo effects of specific compounds, such as zoledronic acid, on senescence markers and the associated secretory phenotype. Kaur's scholarship metrics include an h-index of 15, with over 100 publications and more than 600 citations. She has served as a Co-Principal Investigator on a $395,650 NIH grant focused on developing a minimally invasive biomarker assay for delayed radiation injury. Kaur collaborates extensively with researchers at the University of Arkansas for Medical Sciences, including Elena Ambrogini, Aric Anloague, Sharmin Khan, and Hayley M. Sabol.

Metrics

h-index: 15
Publications: 103
Citations: 623

Positions

Postdoctoral fellow 2022–present

University of Arkansas for Medical Sciences Physiology and Cell Biology ORCID
Post-doctoral Fellow 2020–2022

Mayo Clinic Kogod Aging Center ORCID

Selected Publications

Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)

Figshare DOI OpenAlex
Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)

Figshare DOI OpenAlex
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)

Figshare DOI OpenAlex
Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)

Figshare DOI OpenAlex
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)

Journal of Experimental & Clinical Cancer Research DOI OpenAlex
Expression of miRNAs associated with Cellular Senescence and Osteoporosis in Bone: Insights from Human Biopsies (2025)

SSRN Electronic Journal DOI OpenAlex
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition (2025)

Experimental Hematology and Oncology 3 citations DOI OpenAlex
Examination of Skeletal and Senescence Phenotypes in Young Mice with Juvenile Onset Type 1 Diabetes (2025)

Calcified Tissue International 1 citation DOI OpenAlex
Ex Vivo Model Systems of Cancer-Bone Cell Interactions (2025)

Methods in molecular biology 2 citations DOI OpenAlex
Abstract 5099: Notch inhibition as a therapeutic approach to eliminate dormant cancer cells in multiple myeloma (2025)

Cancer Research DOI OpenAlex